UAE Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Type (Cardiac Monitoring Devices v/s Cardiac Rhythm Management Device), By End User (Hospitals & Clinics, Cardiac Care Centers, Ambulatory Surgery Centers, Others), By Region, Competition Forecast & Opportunities, 2027
UAE Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to register robust growth in the forecast period, 2023-2027. Cardiac monitoring (CM) devices assist in the continuous examination of the cardiac activity of a patient. Cardiac rhythm management (CRM) devices help in maintaining a normal cardiac rhythm in patients suffering from rhythm and rate disorders of the heart. These devices play a significant role in treating numerous cardiac ailments, such as heart failure, atrial flutter, coronary ischemia, lack of oxygen supply to cardiac muscles, indications of recent heart attack, atrial fibrillation, effects of drugs, and certain genetic errors among others. The increasing incidence of cardiac disorders and the growing number of unmet medical needs across the UAE are primarily driving market growth. With this, continuous advancements in the devices and the rising awareness among patients regarding cardiac management devices supports the market growth. The development of new MRI-labelled devices is expected to offer lucrative opportunities for the growth of the cardiac monitoring & cardiac rhythm management sector in the upcoming years.
Elevating Prevalence of Cardiovascular Disease Augments the Market Growth
Cardiovascular disease (CVD) is the major cause of death across the globe. As per the World Health Organization (WHO), CVD approximately 30 million people suffer from a heart attack or stroke every year. A few of the risk factors for CVD include family history, ethnicity, and age. Some of the major causes of cardiovascular ailments include tobacco consumption, high blood pressure (hypertension), high cholesterol, obesity, physical inactivity, diabetes, unhealthy diets, and alcohol consumption which are contributing to the market growth. On account of lifestyle modifications, the number of cases of hypertension, diabetes, dyslipidemia, and obesity, are propelling the rise in the incidence of CVD across the globe. Numerous CVDs can be prevented through pre-monitoring and pre-diagnosis. Several abnormalities in the functioning of the heart, called arrhythmias, can be treated successfully with early diagnosis. This, in turn, is escalating the demand for CM & CRM devices as these devices aid save patients at high risk of cardiac arrest which is supporting the growth of the market in the forthcoming years.
Launch of Advanced Devices is Expected to Boost the Market Growth
Continuous technological advancements and the advent of various innovative products such as durable batteries, MRI pacemakers, and biocompatible materials are primarily driving the growth of the cardiac monitoring devices and cardiac rhythm management market. Cardiac monitoring and cardiac rhythm management devices are widely utilized in hospitals, homes, and ambulatory care. With this, the growing adoption of novel devices along with the technological innovation implemented in the healthcare sector is stimulating market growth. Several leading market players are focusing on developing compact versions of these devices, which are projected to revolutionize the market in the upcoming years.
Market Segmentation
The UAE cardiac monitoring & cardiac rhythm management devices market is segmented into type, end user, regional distribution, and competitive landscape. Based on type, the market is bifurcated into cardiac monitoring devices and cardiac rhythm management devices. Based on end-user, the market is divided into hospitals & clinics, cardiac care centers, ambulatory surgery centers, and others. To analyze the market based on the region, the UAE Cardiac Monitoring & Cardiac Rhythm Management Devices Market is studied in major regions namely Dubai, Abu Dhabi, Sharjah, Rest of UAE.
Market Players
Abbott Laboratories, S.A., Medtronic Meta FZ-LLC, Boston Scientific Corporation, GE Healthcare UAE, Philips Healthcare UAE, Hill-Rom Middle East, and Nihon Kohden Middle East FZE, are the significant market players operating in UAE Cardiac Monitoring & Cardiac Rhythm Management Devices Market.
Report Scope:
In this report, UAE cardiac monitoring & cardiac rhythm management devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in UAE Cardiac Monitoring & Cardiac Rhythm Management Devices market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Elevating Prevalence of Cardiovascular Disease Augments the Market Growth
Cardiovascular disease (CVD) is the major cause of death across the globe. As per the World Health Organization (WHO), CVD approximately 30 million people suffer from a heart attack or stroke every year. A few of the risk factors for CVD include family history, ethnicity, and age. Some of the major causes of cardiovascular ailments include tobacco consumption, high blood pressure (hypertension), high cholesterol, obesity, physical inactivity, diabetes, unhealthy diets, and alcohol consumption which are contributing to the market growth. On account of lifestyle modifications, the number of cases of hypertension, diabetes, dyslipidemia, and obesity, are propelling the rise in the incidence of CVD across the globe. Numerous CVDs can be prevented through pre-monitoring and pre-diagnosis. Several abnormalities in the functioning of the heart, called arrhythmias, can be treated successfully with early diagnosis. This, in turn, is escalating the demand for CM & CRM devices as these devices aid save patients at high risk of cardiac arrest which is supporting the growth of the market in the forthcoming years.
Launch of Advanced Devices is Expected to Boost the Market Growth
Continuous technological advancements and the advent of various innovative products such as durable batteries, MRI pacemakers, and biocompatible materials are primarily driving the growth of the cardiac monitoring devices and cardiac rhythm management market. Cardiac monitoring and cardiac rhythm management devices are widely utilized in hospitals, homes, and ambulatory care. With this, the growing adoption of novel devices along with the technological innovation implemented in the healthcare sector is stimulating market growth. Several leading market players are focusing on developing compact versions of these devices, which are projected to revolutionize the market in the upcoming years.
Market Segmentation
The UAE cardiac monitoring & cardiac rhythm management devices market is segmented into type, end user, regional distribution, and competitive landscape. Based on type, the market is bifurcated into cardiac monitoring devices and cardiac rhythm management devices. Based on end-user, the market is divided into hospitals & clinics, cardiac care centers, ambulatory surgery centers, and others. To analyze the market based on the region, the UAE Cardiac Monitoring & Cardiac Rhythm Management Devices Market is studied in major regions namely Dubai, Abu Dhabi, Sharjah, Rest of UAE.
Market Players
Abbott Laboratories, S.A., Medtronic Meta FZ-LLC, Boston Scientific Corporation, GE Healthcare UAE, Philips Healthcare UAE, Hill-Rom Middle East, and Nihon Kohden Middle East FZE, are the significant market players operating in UAE Cardiac Monitoring & Cardiac Rhythm Management Devices Market.
Report Scope:
In this report, UAE cardiac monitoring & cardiac rhythm management devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- UAE Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Type:
- Cardiac Monitoring Devices
- Cardiac Rhythm Management Device
- UAE Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By End User:
- Hospitals & Clinics
- Cardiac Care Centers
- Ambulatory Surgery Centers
- Others
- UAE Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Region:
- Dubai
- Abu Dhabi
- Sharjah
- Rest of UAE
Company Profiles: Detailed analysis of the major companies present in UAE Cardiac Monitoring & Cardiac Rhythm Management Devices market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UAE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
4. VOICE OF CUSTOMER
5. EXECUTIVE SUMMARY
6. UAE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Cardiac Monitoring Devices v/s Cardiac Rhythm Management Device)
6.2.2. By End User (Hospitals & Clinics, Cardiac Care Centers, Ambulatory Surgery Centers, Others)
6.2.3. By Company (2021)
6.2.4. By Region
6.3. Product Market Map
7. UAE CARDIAC MONITORING DEVICES MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (ECG Devices, Implantable Loop Recorders, Mobile Cardiac Telemetry Devices, Cardiac Output Monitoring Devices, Others)
7.2.2. By End User
8. UAE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Defibrillators v/s Pacemakers)
8.2.2. By End User
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
11. POLICY & REGULATORY LANDSCAPE
12. UAE ECONOMIC PROFILE
13. COMPETITIVE LANDSCAPE
13.1. Abbott Laboratories, S.A.
13.2. Medtronic Meta FZ-LLC
13.3. Boston Scientific Corporation
13.4. GE Healthcare UAE
13.5. Philips Healthcare UAE
13.6. Hill-Rom Middle East
13.7. Nihon Kohden Middle East FZE
14. STRATEGIC RECOMMENDATIONS
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UAE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
4. VOICE OF CUSTOMER
5. EXECUTIVE SUMMARY
6. UAE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Cardiac Monitoring Devices v/s Cardiac Rhythm Management Device)
6.2.2. By End User (Hospitals & Clinics, Cardiac Care Centers, Ambulatory Surgery Centers, Others)
6.2.3. By Company (2021)
6.2.4. By Region
6.3. Product Market Map
7. UAE CARDIAC MONITORING DEVICES MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (ECG Devices, Implantable Loop Recorders, Mobile Cardiac Telemetry Devices, Cardiac Output Monitoring Devices, Others)
7.2.2. By End User
8. UAE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Defibrillators v/s Pacemakers)
8.2.2. By End User
9. MARKET DYNAMICS
9.1. Drivers
9.2. Challenges
10. MARKET TRENDS & DEVELOPMENTS
11. POLICY & REGULATORY LANDSCAPE
12. UAE ECONOMIC PROFILE
13. COMPETITIVE LANDSCAPE
13.1. Abbott Laboratories, S.A.
13.2. Medtronic Meta FZ-LLC
13.3. Boston Scientific Corporation
13.4. GE Healthcare UAE
13.5. Philips Healthcare UAE
13.6. Hill-Rom Middle East
13.7. Nihon Kohden Middle East FZE
14. STRATEGIC RECOMMENDATIONS
